Articles From: Qumu Corporation Closes Sale of Disc Publishing Assets to Owens & Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays


Qumu Corporation (NASDAQ: QUMU), a leader in enterprise video platforms, today announced the closing of its previously announced all-cash sale of the Rimage disc publishing assets to Redwood Acquisition, Inc., a wholly-owned subsidiary of Equus Holdings, Inc. Redwood Acquisition is now known as Rimage Corporation.
Sign-up for Qumu Corporation Closes Sale of Disc Publishing Assets investment picks
Accenture (NYSE:ACN) was named the leader of policy administration deals for its Accenture Life Insurance Platform (ALIP) solution in Celent’s annual report: “North American Insurance Software Deal Trends, 2014 Life/Annuity/Health Edition.” The report analyzes deal data provided by software vendors active in insurance in North America.
Sign-up for Accenture Named Leader of Policy Administration Deals in New Celent Research Report on Life Insurance and Annuity Software Deals in North America investment picks
- Abbott Achieved Top Industry Scores for Economic and Social Performance - Company Recognized for Sustainability Leadership for 10 Consecutive Years ABBOTT PARK, Ill., Sept.
Sign-up for Abbott Once Again Named the Industry Leader for Responsible and Sustainable Business on the Dow Jones Sustainability Index (DJSI) investment picks
OvaScience℠ (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Rodman & Renshaw 16 th Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., on Wednesday, September 10, 2014 at 10:25 am ET at the New York Palace Hotel.
Sign-up for OvaScience to Present at the Rodman & Renshaw/H.C. Wainwright Annual Global Investment Conference investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported second quarter 2014 financial results and highlighted recent accomplishments.
Sign-up for OvaScience Reports Second Quarter 2014 Financial Results investment picks
OvaScience SM (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Company management will present at the Wedbush Securities Life Sciences Management Access Conference on Wednesday, August 13, 2014 at 8:35 am ET at Le Parker Meridian in New York.
Sign-up for OvaScience to Present at the Wedbush Life Sciences Management Access Conference investment picks
OvaScience SM , (NASDAQ:OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 2014 BIO International Convention on Tuesday, June 24, 2014 at 3:00 pm PT at the San Diego Convention Center.
Sign-up for OvaScience to Present at the 2014 BIO International Convention investment picks
OvaScience SM , (NASDAQ: OVAS), a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, announced today that Arthur Tzianabos, Ph.D., Chief Scientific Officer of OvaScience, will present at the JMP Securities Healthcare Conference on Wednesday, June 25, 2014 at 11:30 am ET in The Westin New York Grand Central.
Sign-up for OvaScience to Present at the JMP Securities Healthcare Conference investment picks
NEW YORK, June 20, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc. ("OvaScience" or the "Company") (Nasdaq:OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS investment picks
NEW YORK , July 3, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc. ("OvaScience" or the "Company") (NASDAQ: OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against OvaScience, Inc. and Certain Officers - OVAS investment picks
NEW YORK, July 20, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against OvaScience, Inc ("OvaScience" or the "Company") (Nasdaq:OVAS) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in OvaScience, Inc. of Class Action Lawsuit and Upcoming Deadline -- OVAS investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135121&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against OvaScience, Inc. and Certain Officers - OVAS investment picks
IMS Health (NYSE:IMS) today announced the immediate availability in the U.S. of IDN Impact — a first-of-its-kind solution to measure, compare and prioritize the influence of Integrated Delivery Networks (IDNs) on life sciences brands.
Sign-up for IMS Health’s IDN Impact First to Capture Market Reach, Physician Influence and Brand Dynamics of Integrated Delivery Networks investment picks
IMS Health (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced its intention to acquire certain Cegedim information solutions and Customer Relationship Management (CRM) businesses for €385 million (approximately $520 million) in cash.
Sign-up for IMS Health to Acquire Cegedim’s Information Solutions and CRM Businesses investment picks
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its financial results for second-quarter 2014 on Thursday, July 24, 2014, before the market opens.
Sign-up for IMS Health to Announce Second-Quarter 2014 Results On July 24, 2014 investment picks
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2014.
Sign-up for IMS Health Reports Second-Quarter 2014 Results investment picks
IMS Health (NYSE:IMS) today announced the immediate availability in the U.S. of Nexxus Mobile Sales —the first complete cloud-based sales performance solution for life sciences.
Sign-up for IMS Health Introduces Cloud-Based Life Sciences Solution to Strengthen Customer Engagement, Local Sales Productivity investment picks
Agreement with Beijing government helps transform approaches to air quality management BEIJING , July 7, 2014 /PRNewswire/ -- IBM (NYSE: IBM ) has announced that it is deploying the full force of its researchers in laboratories around the world in a 10-year initiative to support China in transforming its national energy systems and protecting the health of citizens.
Sign-up for IBM Research Launches Project "Green Horizon" to Help China Deliver on Ambitious Energy and Environmental Goals investment picks
2014/8/26
Also acquires stake in Agricen Sciences as part of strategic effort to expand offering of integrated, next-generation plant health technologies LOVELAND, Colo.
Sign-up for Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen investment picks
2014/8/26
Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen Also acquires stake in Agricen Sciences as part of strategic effort to expand offering of integrated, next-generation plant health technologies Canada NewsWire LOVELAND, Colo.
Sign-up for Agrium, through Loveland Products, Acquires a Controlling Interest in Agricultural Biotechnology Company Agricen investment picks
SUGAR LAND, Texas, Aug.
Sign-up for Applied Optoelectronics Introduces Lasers for Methane Sensing investment picks
Provides Superior Value and Immediate Liquidity to GFI Group Shareholders Combination Will Enhance BGC's Brokerage Capabilities and Expand Presence in Energy Markets NEW YORK , Sept.
Sign-up for BGC Partners Announces Intent To Commence All Cash Tender Offer To Acquire GFI Group Shares for $5.25 Per Share investment picks
NEW YORK, June 30, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Indiana on behalf of all persons who purchased or otherwise acquired the securities of Endocyte, Inc. ("Endocyte" or the "Company") (Nasdaq:ECYT) during the period between March 21, 2014 and May 2, 2014 (the "Class Period"). The complaint alleges that during the Class Period, certain of Endocyte's officers issued materially false and misleading statements regarding the Company's prospects for the experimental drug VYNFINIT®. Specifically, on March 21, 2014, Endocyte issued a press release announcing that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued "positive opinions" for the "Conditional Marketing Authorisations" for the drug VYNFINIT®, used to treat platinum-resistant ovarian cancer ("PROC") with VYNFINIT® using testing methods
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Endocyte, Inc. -- ECYT investment picks
SAN DIEGO and WEST LAFAYETTE, Ind.
Sign-up for The Law Office of Robbins Arroyo LLP Announces that it Has Filed a Class Action Lawsuit Against Endocyte, Inc. investment picks
SAN DIEGO and WEST LAFAYETTE, Ind.
Sign-up for Endocyte, Inc. Shareholders: Class Action Lawsuit and Upcoming Deadline investment picks
2014/8/27
By Art Patnaude Real-estate investors from Asia and the Middle East are lining up to bid for two of the most recognizable office buildings in London's skyline, adding heft to the U.K. capital's property boom.
Sign-up for Overseas Investors Line Up for London Office Buildings investment picks
2014/6/26
By Asheesh Advani Extreme-sports enthusiasts use GoPro video cameras to film stunts such as surfing massive waves or jumping out of airplanes.
Sign-up for UPDATE: 4 things GoPro needs to do to succeed investment picks
Owens & Minor, Inc. (NYSE: OMI), a leading healthcare logistics company, and Medical Action Industries Inc. (Nasdaq: MDCI), a leading producer of custom procedure trays (CPTs) and minor procedure kits, announced today that the two companies have signed a definitive agreement under which Owens & Minor will acquire all outstanding shares of Medical Action for $13.80 per share in cash, representing a total transaction value of approximately $208 million, including assumed debt, net of cash.
Sign-up for Owens & Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays investment picks
Acquisition of Medical Action aligns with Owens & Minor's strategy of Connecting the World of Medical Products to the Point of Care TM by expanding reach to the patient Medical Action's kitting capabilities complement Owens & Minor's existing procedure-based delivery service Expected to be accretive to Owens & Minor's non-GAAP net income per diluted share in 2015 and thereafter RICHMOND, Va.
Sign-up for Owens & Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Qumu Corporation Closes Sale of Disc Publishing Assets to Owens & Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices